Tyson Foods, Inc. Announces Quarterly Dividend
May 12, 2017 20:05 pm UTC| Business
SPRINGDALE, Ark., May 12, 2017 -- The Board of Directors of Tyson Foods, Inc. (NYSE:TSN), at a meeting on May 11, 2017, declared a quarterly dividend of $0.225 per share on Class A common stock and $0.2025 per share on...
Lam Research Corporation Declares Quarterly Dividend
May 12, 2017 20:05 pm UTC| Business
FREMONT, Calif., May 12, 2017 -- Lam Research Corporation (Nasdaq:LRCX) today announced that its Board of Directors has approved a quarterly dividend of $0.45 per share of common stock. On an annualized basis, this will...
Cara Therapeutics to Host KOL Meeting on Chronic Kidney Disease-Associated Pruritus on May 16, 2017
May 12, 2017 20:01 pm UTC| Business
STAMFORD, Conn., May 12, 2017 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Forward Reports Fiscal 2017 Second Quarter Results
May 12, 2017 20:01 pm UTC| Business
WEST PALM BEACH, Fla., May 12, 2017 -- Forward Industries, Inc. (NASDAQ:FORD), a designer and distributor of custom carry and protective solutions, today announced financial results for its second fiscal quarter ended...
Allscripts Announces Leadership Change – Dennis Olis Named Interim Chief Financial Officer
May 12, 2017 20:01 pm UTC| Business
CHICAGO, May 12, 2017 -- Allscripts Healthcare Solutions, Inc. today announced that Dennis M. Olis has been named interim chief financial officer. Olis, 54, will report to CEO Paul Black and will replace Melinda...
May 12, 2017 20:01 pm UTC| Business
LAKE SUCCESS, N.Y., May 12, 2017 -- Broadridge Financial Solutions, Inc. (NYSE:BR) today announced that Rich Daly, President and Chief Executive Officer, and Edings Thibault, Head of Investor Relations, will participate...
May 12, 2017 20:00 pm UTC| Business
NEW YORK and SAN DIEGO, May 12, 2017 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a class action lawsuit has been filed against ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”)...